• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Why Biogen is purposefully becoming more risk averse, according to Biogen’s CEO

cafead

Administrator
Staff member
  • cafead   Oct 20, 2023 at 10:13: AM
via Biogen CEO Christopher Viehbacher has been working to course-correct after the company’s ruinous Aduhelm gamble — and shared at the STAT Summit how he plans to move the company forward in a pragmatic way. It’ll still be important to pursue risky projects, he emphasized, but in a more disciplined way.

article source
 

<